Previously working in Regulatory Affairs at Shire before joining PEP-Therapy in 2018 - 3 years of experience in Regulatory Affairs management, Preclinical and Clinical Drug Development.
Pharm D completed with a Master in Pharmaceutical Biotechnology and Innovative Therapy.
This person is not in any teams
PEP-Therapy
PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology based on the Company’s innovative Cell-Penetrating and Interfering Peptides (CP&IP) technology.